PET/MRI may improve diagnosis of Cushing disease
PET/MRI could become the diagnostic method of choice over MRI alone for identifying small pituitary tumors associated with Cushing disease, according to a study published March 21 in the Journal of Nuclear Medicine.
In patients diagnosed with the disease yet who had inconclusive MRI results, PET/MRI was positive in 100% of cases, noted lead author Ilanah Pruis, a doctoral student at Erasmus University Medical Center in Rotterdam, Netherlands.
“This multimodal imaging technique provides a welcome improvement for diagnosis, planning of surgery, and clinical outcome in patients with Cushing disease,” the authors wrote.
...
Source: AuntMinnie.com Headlines - March 29, 2024 Category: Radiology Authors: Will Morton Tags: Molecular Imaging Source Type: news
Co-developer of Cassava ’s potential Alzheimer’s drug cited for ‘egregious misconduct’
Cassava Sciences, a biotech company whose work on the experimental Alzheimer’s drug simufilam has been heavily criticized and is the subject of ongoing federal probes, has suffered another blow. A much-anticipated investigation by the City University of New York has accused neuroscientist Hoau-Yan Wang, a CUNY faculty member and longtime Cassava collaborator, of scientific misconduct involving 20 research papers. Many provided key support for simufilam’s jump from the lab into ongoing clinical trials.
The investigative committee found numerous signs that images were improperly manipulated, for example in a 2012
...
Source: ScienceNOW - October 12, 2023 Category: Science Source Type: news
Aggressive Pituitary Tumors and Pituitary Carcinomas Aggressive Pituitary Tumors and Pituitary Carcinomas
A better understanding of the pathology and clinical course of these rare and challenging tumors could help guide treatment decisions.Journal of Clinical Endocrinology & Metabolism (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 13, 2023 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
Mayo Clinic Q & amp;A podcast: Understanding pituitary tumors
Pituitary tumors are abnormal growths that develop in your pituitary gland. Pituitary tumors can cause too much or too little of the hormones that regulate important functions of your body to be produced. Most pituitary tumors are noncancerous growths called adenomas, which remain in your pituitary gland or surrounding tissues and don't spread to other parts of your body. "It's very uncommon for any pituitary tumor to be a malignancy or what one would commonly… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - December 13, 2022 Category: Databases & Libraries Source Type: news
Russell Watson's tumour felt 'like a knife' in his face - signs of a pituitary lesion
Classical performer Russell Watson shared his excruciating experience with a pituitary tumour. (Source: Daily Express - Health)
Source: Daily Express - Health - December 3, 2022 Category: Consumer Health News Source Type: news
Genomics in Cushing's Disease: The Dawn of a New Era Genomics in Cushing's Disease: The Dawn of a New Era
What can genomic biomarkers tell us about the development and recurrence of pituitary tumors in Cushing ' s disease?Journal of Clinical Endocrinology & Metabolism (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 5, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
Consumer Health: Treating pituitary tumors
The pituitary is a small, bean-shaped gland at the base of your brain, behind your nose and between your ears. Despite its small size, the pituitary gland influences nearly every part of your body. The hormones it produces help regulate important functions, such as growth, blood pressure and reproduction. Pituitary tumors are abnormal growths that [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 8, 2021 Category: Databases & Libraries Source Type: news
Register for the Royal Society of Medicine's webinar series on genetics and endocrinology
The Royal Society of Medicine, in association with the Society for Endocrinology, are holding a three-part webinar series on genetics and endocrinology. This series will take place online on 4-6 May 2021. It will feature experts across both of these fields and provide an overview on a number of topics, including testing for genetic disorders, thyroid disorders, delayed puberty, pituitary tumours and Multiple Endocrine Neoplasia. Find out more and register for all 3 webinars by emailingevents@rsm.ac.uk. (Source: Society for Endocrinology)
Source: Society for Endocrinology - January 20, 2021 Category: Endocrinology Source Type: news
Current Perspectives on Recurrent Pituitary Adenoma Current Perspectives on Recurrent Pituitary Adenoma
Find out more about the available treatment options for recurring pituitary tumors, and learn when revision surgery should be considered.Clinical Endocrinology (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - February 3, 2020 Category: Radiology Tags: Diabetes & Endocrinology Journal Article Source Type: news
New way to study pituitary tumors holds potential for better diagnoses and treatments
(Houston Methodist) Houston Methodist neurosurgeons are looking at a new way to classify pituitary tumors that could lead to more precise and accurate diagnosing for patients in the future. These tests also could have potential for better diagnoses in other brain tumors. The findings, published Jan. 28 in Scientific Reports, describe a new way to study the blood of pituitary adenoma patients to determine tumor type and whether they might respond to medical treatment rather than surgery. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - February 3, 2020 Category: International Medicine & Public Health Source Type: news
North by Northeast - a case of CNS Aspergilloma mistaken for pituitary tumour
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - December 12, 2019 Category: Respiratory Medicine Authors: MeganB Source Type: news
New dad celebrates first father's day after a brain tumor left him infertile
Derin Gebhardt, 37, from Roundup, Montana, was diagnosed in May 2017 with a pituitary tumor, which was causing a decrease in normal levels of sex hormones and behind his infertility. (Source: the Mail online | Health)
Source: the Mail online | Health - June 14, 2019 Category: Consumer Health News Source Type: news
Cushing's disease tumour detection enhanced by hormonal activation
Detecting pituitary tumours in Cushing's patients is enhanced by administration of corticotropin-releasing hormone, according to a study published inEndocrine.Cushing's Disease News (Source: Society for Endocrinology)
Source: Society for Endocrinology - June 12, 2019 Category: Endocrinology Source Type: news
Cambridge drug developer Tiburio launches, targeting pituitary tumors with $31M
A Cambridge startup hoping to develop the first drug treatments to shrink dangerous tumors on the brain's pituitary gland launched Thursday with $31 million in funding.
Tiburio Therapeutics Inc. was spun out of Cambridge orphan disease accelerator Cydan this week with the Series A funding from New Enterprise Associates, Longitude Capital and Alexandria Real Estate Equities Inc.'s (NYSE: ARE) venture arm, Alexandria Venture Investments. Ibsen, which moved its U.S. headquarters to Massachusetts last… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 3, 2019 Category: Biotechnology Source Type: news
Scientists discover intricacies of serotonin receptor crucial for better therapeutics
(University of North Carolina Health Care) For the first time, scientists have figured out why drugs that aim to treat Parkinson's disease, migraines, pituitary tumors, and obesity activate the serotonin receptor 5-HT2B to cause life-threatening heart problems. Published in Nature Structure& Molecular Biology, this research provides drug developers with much needed insights into serotonin receptors -- insights that should help scientists create safer more effective drugs, not just for the aforementioned conditions, but also depression, anxiety, and schizophrenia. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - August 20, 2018 Category: International Medicine & Public Health Source Type: news
